8CES image
Entry Detail
PDB ID:
8CES
Keywords:
Title:
Crystal structure of monkeypox virus methyltransferase VP39 in complex with inhibitor TO500
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2023-02-02
Release Date:
2023-04-05
Method Details:
Experimental Method:
Resolution:
2.50 Å
R-Value Free:
0.28
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase
Chain IDs:A, B
Chain Length:307
Number of Molecules:2
Biological Source:Monkeypox virus
Ligand Molecules
Primary Citation
Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase.
Nat Commun 14 2259 2259 (2023)
PMID: 37080993 DOI: 10.1038/s41467-023-38019-1

Abstact

Monkeypox is a disease with pandemic potential. It is caused by the monkeypox virus (MPXV), a double-stranded DNA virus from the Poxviridae family, that replicates in the cytoplasm and must encode for its own RNA processing machinery including the capping machinery. Here, we present crystal structures of its 2'-O-RNA methyltransferase (MTase) VP39 in complex with the pan-MTase inhibitor sinefungin and a series of inhibitors that were discovered based on it. A comparison of this 2'-O-RNA MTase with enzymes from unrelated single-stranded RNA viruses (SARS-CoV-2 and Zika) reveals a conserved sinefungin binding mode, implicating that a single inhibitor could be used against unrelated viral families. Indeed, several of our inhibitors such as TO507 also inhibit the coronaviral nsp14 MTase.

Legend

Protein

Chemical

Disease

Primary Citation of related structures